Reversal of the glycolytic phenotype of primary effusion lymphoma cells by combined targeting of cellular metabolism and PI3K/Akt/ mTOR signaling

Laura Mediani, Federica Gibellini, Jessika Bertacchini, Chiara Frasson, Raffaella Bosco, Benedetta Accordi, Giuseppe Basso, Massimo Bonora, Maria Luisa Calabrò, Adriana Mattiolo, Gianluca Sgarbi, Alessandra Baracca, Paolo Pinton, Giovanni Riva, Enrico Rampazzo, Luca Petrizza, Luca Prodi, Daniela Milani, Mario Luppi, Leonardo Potenza, Anto De Pol, Lucio Cocco, Silvano Capitani, Sandra Marmiroli
  • Oncotarget, November 2015, Impact Journals, LLC
  • DOI: 10.18632/oncotarget.6315

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.18632/oncotarget.6315

The following have contributed to this page: Luca Prodi